Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of United Parcel Service, Inc. UPS fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales guidance below estimates.

UPS reported a fourth-quarter fiscal 2023 revenue decline of 7.8% year-over-year to $24.92 billion, missing the consensus of $25.43 billion. Adjusted EPS was $2.47, down from $3.62 in Q4 2022, in line with the consensus.

United Parcel Service shares dipped 8.3% to $145.04 on Tuesday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Agape ATP Corporation ATPC shares jumped 79% to $0.9120.
• Pixelworks, Inc. PXLW rose 56.8% to $2.3209 after the company entered into a multi-year agreement with Walt Disney Studios.
• Agrify Corporation AGFY surged 50.7% to $0.9120 after a 13D filing showed I-Tseng Jenny Chan reported a 49.99% stake in the company.
• Rail Vision Ltd. RVSN gained 38.8% to $20.38 after the company announced its next generation AI-based computer to be incorporated in its Main Line and Switch Yard systems.
• Inspire Veterinary Partners, Inc. IVP climbed 38% to $0.2359 after falling around 24% on Monday. Inspire Veterinary Partners recently filed a prospectus related to up to a $5 million public offering.
• Sanmina Corporation SANM shares climbed 36.7% to $69.21 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.
• Selina Hospitality PLC SLNA gained 20.8% to $0.4603.
• C3is Inc. CISS shares surged 19.1% to $0.1609 after a 13G filing showed S.H.N. Financial reported a 9.1% stake in the company.
• Brainstorm Cell Therapeutics Inc. BCLI rose 18.2% to $0.39.
• Kura Oncology, Inc. KURA climbed 16.1% to $21.60. Kura Oncology reported preliminary ziftomenib combination data in acute myeloid leukemia.
• Petros Pharmaceuticals, Inc. PTPI gained 13.9% to $1.56 after gaining more than 25% on Monday. Petros Pharmaceuticals recently announced completion of initial cohort of Phase 2 equivalent self-selection study.
• Tivic Health Systems, Inc. TIVC rose 13.1% to $1.55.
• Nuvve Holding Corp. NVVE gained 12.7% to $3.5380. Nuvve won a $16 million contract from Fresno EOC to 'transition EV fleet without taxing the powergrid."
• Commvault Systems, Inc. CVLT gained 11.6% to $91.01 following strong quarterly results.
• Helmerich & Payne, Inc. HP rose 11.6% to $40.49 following upbeat earnings.
• Merchants Bancorp MBIN gained 9.2% to $47.96. Raymond James analyst Daniel Tamayo maintained Merchants Bancorp with a Strong Buy and raised the price target from $44 to $55.
• Nayax Ltd. NYAX climbed 8.4% to $25.15.
• Corning Incorporated GLW surged 8% to $33.62 following strong sales.
• General Motors Company GM gained 7.6% to $38.06 after the company reported better-than-expected fourth-quarter financial results and issued 2024 adjusted EPS guidance above estimates.
• Celestica Inc. CLS gained 4.6% to $34.06 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.

Losers

• Baijiayun Group Ltd RTC shares dipped 66.4% to $2.50.
• Meiwu Technology Company Limited WNW tumbled 49% to $3.93.
• Sidus Space, Inc. SIDU shares fell 42.7% to $4.9863 after the company announced the pricing of its public offering of 1,251,700 Class A shares at $4.50 per share.
• 60 Degrees Pharmaceuticals, Inc. SXTP fell 40.1% to $0.31 after the company announced pricing of a $2.4 million public offering.
• Palisade Bio, Inc. PALI fell 32% to $0.6550. Palisade Bio announced exercise of previously issued warrants for $2.5 million.
• Nyxoah S.A. NYXH dipped 39% to $7.53 after surging 31% on Monday.
• Revelation Biosciences, Inc. REVB shares dipped 28.4% to $9.30 after gaining around 32% on Monday.
• Calix, Inc. CALX declined 26.6% to $32.56 after the company issued first-quarter adjusted EPS and revenue guidance below estimates.
• Aileron Therapeutics, Inc. ALRN dipped 25.4% to $4.53.
• CNS Pharmaceuticals, Inc. CNSP shares fell 24.5% to $0.2504 after the company reported pricing of $4.0 million public offering.
• IM Cannabis Corp. IMCC dipped 22% to $0.2520.
• Solowin Holdings SWIN fell 21.7% to $5.05.
• Jianpu Technology Inc. JT declined 21.2% to $0.3785.
• Addex Therapeutics Ltd ADXN fell 21.1% to $10.50 after gaining 7% on Monday.
• Adtalem Global Education Inc. ATGE dipped 20.5% to $46.60. CNBC reported that short seller Fahmi Quadir has taken a short position in the stock.
• Richtech Robotics Inc. RR fell 19.1% to $2.2640.
• Motus GI Holdings, Inc. MOTS fell 17% to $0.7751. Motus GI Holdings publishesd results from European study of second generation Pure-Vu System in improving visualization for colonoscopy Ib patients with history of poor bowel preparation.
• Malibu Boats, Inc. MBUU fell 15.5% to $43.08 after the company reported mixed second-quarter financial results.
• AEON Biopharma, Inc. AEON dipped 15.5% to $7.20.
• Weatherford International plc WFRD declined 14.7% to $85.00.
• OneMedNet Corporation ONMD shares fell 13.9% to $1.18 after jumping 156% on Monday.
• Borr Drilling Limited BORR fell 11.2% to $6.56.
• Prothena Corporation plc PRTA fell 9.8% to $30.43. B of A Securities analyst Tazeen Ahmad downgraded Prothena from Buy to Neutral and lowered the price target from $68 to $38.
• Schlumberger Limited SLB fell 9.4% to $48.18. Schlumberger Chief Sustainability Officer Katharina Beumelburg sold a total of 8,000 shares at an average price of $52.63.
• Infobird Co., Ltd IFBD declined 9.4% to $0.6430 after gaining around 35% on Monday.
• Tidewater Inc. TDW fell 7.1% to $68.21.
• Whirlpool Corporation WHR shares declined 6.7% to $109.81 after the company issued 2024 ongoing EPS and net sales guidance below estimates.
• NOV Inc. NOV dipped 6.5% to $19.64.
• Johnson Controls International plc JCI fell 4.7% to $53.99 after the company reported mixed first-quarter results and cut its FY24 EPS guidance.
• A. O. Smith Corporation AOS fell 4.4% to $77.76 following quarterly results.

Now Read This: Goldman Sachs, AbbVie And A Major Chipmaker: CNBC's 'Final Trades'